Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)

Shahid Beheshti University of Medical Sciences

Status and phase: Unknown; Phase 3

Conditions: Diabetic Retinopathy

Treatments: Drug: bevacizumab

Study type: Interventional

Funder types: Other

Identifiers

NCT00370721

8538

Details and patient eligibility

About

To evaluate the effect of intravitreal bevacizumab on the course of diabetic retinopathy in cases with the signs of active progressive PDR

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Cases of active progressive PDR with history of scatter laser photocoagulation

Exclusion criteria

• history of vitrectomy

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

I

Experimental group

Treatment:

Drug: bevacizumab